. Larger late sodium current density as well as greater sensitivities to ATX II and ranolazine in rabbit left atrial than left ventricular myocytes. Am J Physiol Heart Circ Physiol 306: H455-H461, 2014. First published December 6, 2013 doi:10.1152/ajpheart.00727.2013.-An increase of cardiac late sodium current (INa.L) is arrhythmogenic in atrial and ventricular tissues, but the densities of INa.L and thus the potential relative contributions of this current to sodium ion (Na ϩ ) influx and arrhythmogenesis in atria and ventricles are unclear. In this study, whole-cell and cell-attached patch-clamp techniques were used to measure INa.L in rabbit left atrial and ventricular myocytes under identical conditions. The density of INa.L was 67% greater in left atrial (0.50 Ϯ 0.09 pA/pF, n ϭ 20) than in left ventricular cells (0.30 Ϯ 0.07 pA/pF, n ϭ 27, P Ͻ 0.01) when elicited by step pulses from Ϫ120 to Ϫ20 mV at a rate of 0.2 Hz. Similar results were obtained using step pulses from Ϫ90 to Ϫ20 mV. Anemone toxin II (ATX II) increased INa.L with an EC50 value of 14 Ϯ 2 nM and a Hill slope of 1.4 Ϯ 0.1 (n ϭ 9) in atrial myocytes and with an EC50 of 21 Ϯ 5 nM and a Hill slope of 1.2 Ϯ 0.1 (n ϭ 12) in ventricular myocytes. Na ϩ channel open probability (but not mean open time) was greater in atrial than in ventricular cells in the absence and presence of ATX II. The INa.L inhibitor ranolazine (3, 6, and 9 M) reduced INa.L more in atrial than ventricular myocytes in the presence of 40 nM ATX II. In summary, rabbit left atrial myocytes have a greater density of INa.L and higher sensitivities to ATX II and ranolazine than rabbit left ventricular myocytes. regional differences; late sodium current; patch-clamp technique; cardiomyocyte ATRIAL FIBRILLATION (AF) IS the most common cardiac rhythm disturbance and contributes substantially to cardiac morbidity and mortality. Safe and effective pharmacologic management of AF is one of the greatest challenges facing an aging society. The role of electrical heterogeneity in development of cardiac arrhythmias is well recognized (6, 19, 28) , and atrial-specific currents, including the transient outward current, the ultrarapidly activating delayed rectifier current, and the acetylcholineactivated current, are reported to contribute to arrhythmogenesis in the atria. The density of sodium ion (Na ϩ ) channels is also reported to be greater in atrial than in ventricular myocardium (10, 15), and the Na ϩ channel blockers ranolazine and amiodarone exert an atrial-selective sodium channel block to suppress and/or prevent effectively the induction of AF in experimental models. Therefore, an atrial-selective sodium channel block is a new strategy for the management of AF (4, 5, 7-10, 26).
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Myocardial Na ϩ channels open briefly upon membrane depolarization to allow the passage of a large peak inward Na ϩ current that is responsible for the upstroke of the cardiac action potential. Na ϩ channel openings during the subsequent plateau phase of the cardiac action potential are few, but they allow further Na ϩ entry that creates a small, persistent or late sodium current (I Na.L ). I Na.L plays an important role in maintaining the plateau of the action potential. An increase of I Na.L may increase the duration of the action potential, the transmural dispersion of repolarization, and the Na ϩ loading of myocardial cells (22) . I Na.L also contributes to arrhythmogenesis (e.g., afterdepolarizations and triggered arrhythmias) in ventricular myocardium (2) and to afterdepolarizations and spontaneous diastolic depolarizations in atrial myocytes (23, 24) .
The density of I Na.L in various regions of the myocardium is likely to be relevant to its importance as a mechanism of arrhythmic activity. Persson et al. (20) reported that the densities of I Na.L in rabbit right atrial and right ventricular myocytes were similar. However, to our knowledge, no study comparing the densities of I Na.L between left atrial and left ventricular cells has been reported. Therefore, we determined the density of I Na.L in rabbit left atrial and ventricular cells under the same conditions. The effects of the I Na.L opener anemone toxin II (ATX II) and the selective I Na.L inhibitor ranolazine on atrial and ventricular cells were also determined to gain further insight into the relative roles of I Na.L in these two types of myocytes.
MATERIALS AND METHODS
Current recordings. The use of animals in this investigation was approved by the Institutional Animal Care and Use Committee of Wuhan University of Science and Technology and conformed to the Guide for the Care and Use of Laboratory Animals (National Institutes of Health publication no. 85-23). Left atrial and left ventricular cardiomyocytes were isolated enzymatically from hearts of rabbits of both sexes, as described previously (16) . For whole-cell recordings, the electrode resistance (when filled with pipette solution) was 1.5-2 M⍀. For single-channel recordings, the shanks of pipettes with resistance of 6 -10 M⍀ were coated with Sylgard, and the tips were heat polished. Capacitance and series resistances were adjusted to obtain minimal contribution of the capacitive transients. A 60 -80% compensation of the series resistance was achieved without ringing. Currents were obtained with a patch-clamp amplifier (EPC 9; HEKA Electronik, Lambrecht/Pfalz, Germany), filtered at 2 kHz, and digitized at 10 kHz. All experiments were conducted at 22-25°C.
Whole-cell currents were elicited by 300 ms depolarizing pulses from a holding potential of Ϫ120 or Ϫ90 mV to Ϫ20 mV at a frequency of 0.2 Hz. The amplitude of I Na.L was measured at 200 ms after initiation of a depolarizing step to eliminate any contribution from transient sodium current (1) . Current density was calculated by dividing current amplitude by the cell capacitance.
Single-channel currents were activated by a 700-ms voltage pulse from Ϫ120 to Ϫ50 mV at a frequency of 0.2 Hz. The current at Ն50 ms after onset of the depolarizing pulse was used to calculate I Na.L The statistical significance of differences was determined using one-way ANOVA, followed by a Tukey multiple comparison test or Student's unpaired t-test. All values are expressed as mean Ϯ SD.
RESULTS
Larger I Na.L density in rabbit atrial than in rabbit ventricular myocytes in the absence and presence of ATX II. Under control conditions (absence of drug), the amplitude of I Na.L was similar in atrial (23.6 Ϯ 6.6 pA, n ϭ 20) and ventricular cells (26.1 Ϯ 5.7 pA, n ϭ 27, P Ͼ 0.05). However, the cell capacitance of left ventricular myocytes (88 Ϯ 14 pF, n ϭ 27) was significantly larger than that of left atrial myocytes (47 Ϯ 10 pF, n ϭ 20, P Ͻ 0.01). Cell capacitances of right ventricular and right atrial myocytes were 77 Ϯ 19 pF (n ϭ 25) and 67 Ϯ 16 pF (n ϭ 8; P Ͼ 0.05), respectively. As shown in Fig. 1 , after normalization for cell capacitance, the density of I Na.L in left atrial myocytes (0.50 Ϯ 0.09 pA/pF, n ϭ 20) was significantly greater (P Ͻ 0.01) than in left ventricular myocytes (0.30 Ϯ 0.07 pA/pF, n ϭ 27; Fig. 1, A-D) . The effect of holding potential on I Na.L in left atrial and ventricular myocytes was determined. The densities of I Na.L , measured from holding potentials of Ϫ90 and Ϫ120 mV, were similar in left atrial (0.45 Ϯ 0.11 vs. 0.45 Ϯ 0.10 pA/pF, n ϭ 9, P Ͼ 0.05) and ventricular myocytes (0.28 Ϯ 0.08 vs. 0.28 Ϯ 0.10 pA/pF, n ϭ 9, P Ͼ 0.05), although peak I Na was reduced at Ϫ90 relative to Ϫ120 mV (not shown). This result suggests that differences in resting membrane potential between normal left atrial and ventricular myocytes may not have a significant effect on the density of I Na.L .
ATX II increased the I Na.L in both atrial and ventricular myocytes in a concentration-dependent manner (Fig. 1, A-E) . In ventricular cells, ATX II (5, 10, 20, and 40 nM) increased I Na.L (at Ϫ20 mV) to 134 Ϯ 12%, 165 Ϯ 15%, 203 Ϯ 24%, and 248 Ϯ 32% of control (n ϭ 12, all P Ͻ 0.01 vs. control), respectively. In atrial cells, I Na.L was increased to 143 Ϯ 7%, 189 Ϯ 28%, 234 Ϯ 30%, and 278 Ϯ 33% of control (n ϭ 9, all P Ͻ 0.01 vs. control), respectively. The enhancement of I Na.L relative to control was larger in atrial myocytes than in ventricular myocytes at each concentration of ATX II (P Ͻ 0.05; Fig. 1E ). The amplitude of I Na.L in atrial myocytes was increased by ATX II with an EC 50 of 14 Ϯ 2 nM and a Hill slope of 1.4 Ϯ 0.1 (n ϭ 9) and in ventricular myocytes, with an EC 50 of 21 Ϯ 5 nM and a Hill slope of 1.2 Ϯ 0.1 (n ϭ 12; Fig. 1E ).
Greater Na ϩ channel open probability in rabbit atrial than in ventricular myocytes in the absence and presence of ATX II. To explore the mechanism underlying the above results, the cell-attached, single-channel patch-clamp technique was used to record Na ϩ channel activities in atrial and ventricular myocytes. Under control conditions, the mean open probability of Na ϩ channels at a membrane potential of Ϫ50 mV in atrial cells was greater than that in ventricular cells (0.011 Ϯ 0.001 vs. 0.007 Ϯ 0.001, both n ϭ 7, P Ͻ 0.01; Figs. 2 and 3) . However, Na
ϩ channel mean open time was similar in atrial and ventricular myocytes (0.341 Ϯ 0.027 and 0.324 Ϯ 0.033 ms, both n ϭ 7, P Ͼ 0.05). The extracellular face of membrane Na ϩ channels was exposed to ATX II by adding the toxin to the electrolyte solution in the recording pipette. ATX II increased Na ϩ channel activities in both atrial and ventricular myocytes in a concentration-dependent manner (Figs. 2 and 3) . The mean open probability of Na ϩ channels in atrial myocytes was greater than that for Na ϩ channels in ventricular myocytes (Figs. 2 and 3A) . However, channel mean open times in atrial and ventricular myocytes were not different (Fig. 3B) .
Ranolazine inhibited ATX II-induced I Na.L more in atrial than in ventricular myocytes. In the presence of 40 nM ATX II, ranolazine decreased I Na.L in both atrial and ventricular myocytes in a concentration-dependent manner (Fig. 4) . In ventricular cells, the percentage inhibitions by 3, 6, and 9 M ranolazine of ATX II-stimulated I Na.L were 24 Ϯ 6%, 44 Ϯ 8%, and 62 Ϯ 4% (n ϭ 7), respectively. In atrial cells, the percentage inhibitions were 35 Ϯ 7%, 55 Ϯ 6%, and 72 Ϯ 6% (n ϭ 6), respectively. The percentage inhibitions by 3, 6, and 9 M ranolazine of ATX II-stimulated I Na.L in atrial myocytes were greater than those in ventricular myocytes (all P Ͻ 0.05; Fig. 4E ).
DISCUSSION
In the present study, we found that the amplitudes of I Na.L in rabbit left atrial and ventricular myocytes were similar, but left atrial myocytes had a significantly smaller capacitance (i.e., smaller area of sarcolemmal membrane) and therefore, a higher density of I Na.L than left ventricular myocytes (Fig. 1) . In cell-attached recordings, the Na ϩ channel open probability at Ϫ50 mV in left atrial cells was greater than that in left ventricular cells in the absence and presence of ATX II (Figs.  2 and 3) . Moreover, in whole-cell patch-clamp experiments, left atrial myocytes had higher sensitivities to ATX and ranolazine than left ventricular cells (Fig. 4) . These results, in combination, support the conclusion that the density of I Na.L is greater in rabbit left atrial than left ventricular myocytes and are consistent with earlier reports that the density of peak I Na is significantly greater in atrial than in ventricular myocytes (10, 15) . The findings suggest that the effects of enhancers and blockers of I Na.L may be subtly different in each of the four heart chambers.
An increase of I Na.L can play an important role in the genesis of atrial arrhythmic activity (22) . Song et al. (23, 24) reported that an increase of I Na.L , stimulated by ATX II, induces delayed afterpolarizations and sustained triggered activity, as well as spontaneous diastolic depolarization, leading to pacemaking in guinea pig atrial myocytes. Guo et al. (12) reported that both arrhythmic activity and the density of I Na.L were increased in left atrial myocytes of rabbits, with left ventricular hypertrophy induced by renovascular hypertension. In myocytes isolated from right atrial appendages of patients with AF, Sossalla et al. (25) found that the density of peak I Na was reduced, but the density of I Na.L was increased relative to the densities of these currents in atrial myocytes isolated from right atria of patients in sinus rhythm. The I Na.L inhibitor ranolazine suppressed arrhythmic activity of isolated atrial myocytes in these previous studies (12, (23) (24) (25) . Ranolazine is a selective inhibitor of I Na.L relative to peak I Na (3) , and the drug is reported to decrease the incidence of atrial arrhythmias in patients with paroxysmal AF (18) . The greater effect of ranolazine in the present study to reduce atrial rather than ventricular I Na.L (Fig. 4 ) may contribute to its beneficial effect in the management of AF.
The present results are different from those in a previous study by Persson et al. (20) , who reported that the capacitance and densities of I Na.L in rabbit right atrial and ventricular cells were similar. The discrepancy may be due to the use of left heart (our study) vs. right heart [Persson et al. (20) ] tissues, as we observed that cell capacitance (i.e., cell size) was significantly greater for left ventricular than for left atrial myocytes but similar when comparing right ventricular with right atrial myocytes.
We caution that our experiments were done at room temperature and that results at physiological temperature may differ from those found in this study. Nonetheless, a strength of the current investigation is that I Na.L and its responses to ATX II and ranolazine were measured under identical conditions in atrial and ventricular myocytes to enable a comparison of I Na.L in these cell types. The results of this study should be extrapolated with caution from rabbit to human because of potentially important regional differences in Na ϩ channel expression and/or regulation between the two species. Lastly, although the mechanism of the observed differences in I Na.L density and channel open probability between atrial and ventricular myocytes was not explored, we speculate that differential expression of Na ϩ channel ␤ subunits in atrial and ventricular myocytes (11, 21) may be relevant. Sodium channel ␤ subunits have been shown to modulate cardiomyocyte I Na.L and Na ϩ channel gating (14, 17, 21) .
In summary, rabbit left atrial myocytes show a greater density of I Na.L and higher sensitivity to ATX II and ranolazine than left ventricular myocytes. These results may help to explain previous findings that enhancement of I Na.L in atrial tissue is arrhythmogenic, and inhibition of the current is beneficial to reduce arrhythmic activity. 
